Matches in Nanopublications for { <http://bio2rdf.org/drugbank:DB05750> ?p ?o ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05750 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05750 label "AVE-1625 [drugbank:DB05750]" assertion.
- drugbank:DB05750 seeAlso DB05750 assertion.
- drugbank:DB05750 description "AVE-1625 is an oral selective and potent antagonist of cannabinoid 1 (CB1) receptors having the same mechanism of action as rimonabant. It is currently developed in obesity and its associated comorbidities. AVE-1625 is also being developed for the treatment of Alzheimer disease." assertion.
- drugbank:DB05750 identifier "drugbank:DB05750" assertion.
- drugbank:DB05750 title "AVE-1625" assertion.
- drugbank:DB05750 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05750 drugbank_vocabulary:drugbank-id "DB05750" assertion.
- drugbank:DB05750 bio2rdf_vocabulary:x-identifiers.org DB05750 assertion.
- drugbank:DB05750 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05750" assertion.
- drugbank:DB05750 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05750 bio2rdf_vocabulary:identifier "DB05750" assertion.